Table 3.
Overall | Group 1 | Group 2 | p value | |
---|---|---|---|---|
Target cores positive | 158/228 (69.3 %) | 76/106 (71.7 %) | 82/122 (67.2 %) | 0.476 |
Background cores positive | 344/1881 (18.38 %) | 101/876 (11.5 %) | 243/1005 (24.2 %) | <0.001 |
Core mean length: range (median) | 5.6–14.7 (10.35) | 5.6–14.7 (10.15) | 6.5–14.5 (10.5) | 0.555 |
Final Gleason grade | (n = 76) | (n = 41) | (n = 48) | 0.122 |
3 + 3 | 9 (11.8 %) | 8 (9 %) | 3 (3.4 %) | |
3 + 4 | 32 (42.1 %) | 21 (23.6 %) | 19 (21.3 %) | |
4 + 3 | 14 (18.4 %) | 4 (4.5 %) | 12 (13.4 %) | |
8 | 5 (6.6 %) | 3 (3.4 %) | 3 (3.4 %) | |
9 | 15 (19.7 %) | 5 (5.6 %) | 10 (11.2 %) | |
10 | 1 (1.4 %) | 0 (0 %) | 1 (1.1 %) |
Group 1: target biopsy cores show higher Gleason grade; Group 2: target sector biopsy cores show equal or higher Gleason grade. Overall “final Gleason grade” listed as highest Gleason score per patient